Gilead Sciences, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABBV
|
AbbVie Inc. | $200.51 | $299.17 B | 50.57 | 50000 | $54.32 B |
 AMGN
|
Amgen Inc. | $321.98 | $163.62 B | 43.57 | 26700 | $28.19 B |
 AZN
|
AstraZeneca PLC | $64.69 | $248.10 B | 39.42 | 89900 | $45.81 B |
 BMY
|
Bristol-Myers Squibb Company | $54.72 | $84.08 B | -13.38 | 34100 | $45.01 B |
 JNJ
|
Johnson & Johnson | $156.71 | $353.97 B | 21.85 | 131900 | $85.16 B |
 LLY
|
Eli Lilly and Company | $797.53 | $807.83 B | 125.37 | 43000 | $34.12 B |
 MRK
|
Merck & Co., Inc. | $101.18 | $330.96 B | 143.59 | 70000 | $60.12 B |
 PFE
|
Pfizer Inc. | $27.46 | $161.95 B | -571.6 | 88000 | $58.50 B |